Long-acting new lambda interferon(Beijing Tri-Prime Genetic Engineering)
N/A
Report date: 2025/03/18 11:34:38
Base Information
Drug NameLong-acting new lambda interferon(Beijing Tri-Prime Genetic Engineering)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Tri-Prime Gene Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Tri-Prime Gene Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A